Hualan Biological Engineering Inc. (SHE:002007)
China · Delayed Price · Currency is CNY 15.00
+0.06 (0.40%)
Apr 15, 2026, 11:40 AM CST
SHE:002007 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 940.4 | 1,088 | 1,482 | 1,076 | 1,299 |
Depreciation & Amortization | 274.45 | 261.03 | 259.59 | 272.82 | 196.45 |
Other Amortization | 7.1 | 11.31 | 14.2 | 14.77 | 10.04 |
Loss (Gain) From Sale of Assets | -2.89 | -0.08 | -44.44 | -47.67 | -0.42 |
Asset Writedown & Restructuring Costs | 3.53 | 5.71 | 9.71 | 1.19 | 3.23 |
Loss (Gain) From Sale of Investments | -77.67 | -170.46 | -209.59 | -144.05 | -100.22 |
Provision & Write-off of Bad Debts | 34.06 | -5.59 | 13.92 | 32.83 | 11.29 |
Other Operating Activities | 127.8 | 154.97 | 384.37 | 358.97 | 309.88 |
Change in Accounts Receivable | -423.1 | 840.46 | -302.66 | -538.11 | 162.97 |
Change in Inventory | -317.32 | -416.88 | -316.45 | -245.23 | -317.36 |
Change in Accounts Payable | 333.3 | -723.83 | 7.97 | 190.01 | -137.32 |
Change in Other Net Operating Assets | -28.16 | 11.15 | 34.82 | 6.36 | 4.14 |
Operating Cash Flow | 877.96 | 1,059 | 1,346 | 957.31 | 1,432 |
Operating Cash Flow Growth | -17.12% | -21.29% | 40.59% | -33.17% | 8.09% |
Capital Expenditures | -197.31 | -255.43 | -753.41 | -393.95 | -811.35 |
Sale of Property, Plant & Equipment | 2.69 | 0.89 | 204.11 | 50.32 | 0.91 |
Divestitures | - | 1.55 | - | - | - |
Investment in Securities | 464.89 | 208.13 | -536.92 | -2,175 | -1,075 |
Other Investing Activities | 264.01 | 134.93 | 87.94 | 68.89 | 126.6 |
Investing Cash Flow | 534.28 | 90.08 | -998.28 | -2,450 | -1,759 |
Short-Term Debt Issued | 724.94 | 596.47 | - | - | - |
Long-Term Debt Issued | - | - | 700 | 1,100 | 1,300 |
Total Debt Issued | 724.94 | 596.47 | 700 | 1,100 | 1,300 |
Short-Term Debt Repaid | -1,179 | -700 | - | - | - |
Long-Term Debt Repaid | - | -0.95 | -600.38 | -1,001 | -700 |
Total Debt Repaid | -1,179 | -700.95 | -600.38 | -1,001 | -700 |
Net Debt Issued (Repaid) | -454.44 | -104.48 | 99.62 | 99.24 | 600 |
Issuance of Common Stock | - | 16.28 | 48.07 | 2,255 | - |
Repurchase of Common Stock | -14.02 | -106.79 | - | - | - |
Common Dividends Paid | -1,361 | -467.83 | -563.64 | -399.47 | -564.11 |
Other Financing Activities | -167.12 | -117.62 | -39 | -36.57 | - |
Financing Cash Flow | -1,997 | -780.43 | -454.96 | 1,918 | 35.89 |
Foreign Exchange Rate Adjustments | 0.14 | -0.05 | 0.06 | 0.05 | -0.03 |
Net Cash Flow | -584.68 | 368.94 | -107.33 | 425.29 | -290.45 |
Free Cash Flow | 680.65 | 803.92 | 592.43 | 563.36 | 621.15 |
Free Cash Flow Growth | -15.33% | 35.70% | 5.16% | -9.30% | -11.75% |
Free Cash Flow Margin | 14.81% | 18.36% | 11.09% | 12.47% | 14.00% |
Free Cash Flow Per Share | 0.37 | 0.44 | 0.33 | 0.31 | 0.34 |
Cash Income Tax Paid | 395.87 | 494.25 | 503.9 | 457.29 | 564.96 |
Levered Free Cash Flow | 408.59 | 1,422 | 276.91 | -258.06 | 252 |
Unlevered Free Cash Flow | 414.99 | 1,431 | 285.14 | -239.15 | 265.58 |
Change in Working Capital | -428.82 | -285.4 | -563.51 | -607.8 | -296.66 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.